Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance-Reference-Cited by-同舟云学术

Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance

Published:2018-04-25 Issue:3 Volume:23 Page:e12485
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Long Xiaohua¹^ORCID,Chen Qi¹,Yu Lou¹,Liang Xiao¹,Liu Wenzhong¹,Lu Hong¹

Affiliation:

1. Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology; Ministry of Health; Renji Hospital; School of Medicine; Shanghai Institute of Digestive Disease; Shanghai Jiao Tong University; Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hel.12485/fullpdf

Reference24 articles.

1. High prevalence rate of Helicobacter pylori resistance to clarithromycin during long-term multiple antibiotic therapy for chronic respiratory disease caused by non-tuberculous mycobacteria;Kaneko;Aliment Pharmacol Ther,2004

2. Review article: the global emergence of Helicobacter pylori antibiotic resistance;Thung;Aliment Pharmacol Ther,2016

3. Antibiotic resistance of Helicobacter pylori among male United States Veterans;Shiota;Clin Gastroenterol Hepatol,2015